https://ift.tt/2IVHF6y

HDFC Securities has 'buy' rating on Sun Pharma with a 12-month target price of Rs 545 as the brokerage expects a recovery in the profitability (24 per cent margin) by FY21E.

from Markets https://ift.tt/2zuAICe

Comments

Popular posts from this blog

IIT PhDs in demand for high-end R&D jobs

India Inc turn to non-bank routes for funding